Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Publisher Correction: ‘Super-antibodies’ could curb COVID-19 and help avert future pandemics

The Original Article was published on 22 June 2021

Correction to: Nature Biotechnology https://doi.org/10.1038/s41587-021-00980-x, published online 22 June 2021.

In the version of this article initially published online, the name of the company Vir Biotechnology was given as Vir Therapeutics. The error has been corrected in the print, PDF and HTML versions of the article.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Elie Dolgin.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Dolgin, E. Publisher Correction: ‘Super-antibodies’ could curb COVID-19 and help avert future pandemics. Nat Biotechnol 39, 893 (2021). https://doi.org/10.1038/s41587-021-00997-2

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing